Cost and effectiveness analyses of the anti-osteoporosis medication in patients with hip fracture in Taiwan: A population-based national claims database analysis-Reference-Cited by-同舟云学术

Cost and effectiveness analyses of the anti-osteoporosis medication in patients with hip fracture in Taiwan: A population-based national claims database analysis

Published:2023 Issue: Volume:122 Page:S92-S100
ISSN:0929-6646
Container-title:Journal of the Formosan Medical Association
language:en
Short-container-title:Journal of the Formosan Medical Association

Author:

Wang Chen-Yu,Wu Chih-Hsing,Chen Ho-Min,Lin Jou-Wei,Hsu Chih-Cheng,Chang Yin-Fan,Tai Ta-Wei,Fu Shau-Huai,Hwang Jawl-Shan^ORCID

Publisher

Elsevier BV

Subject

General Medicine

Reference22 articles.

1. Fragility fractures in Europe: burden, management and opportunities;Borgström;Arch Osteoporos,2020

2. GBD 2019 Fracture Collaborators. Global, regional, and national burden of bone fractures in 204 countries and territories, 1990-2019: a systematic analysis from the Global Burden of Disease Study 2019;Lancet Healthy Longev,2021

3. The cost effectiveness of bisphosphonates for the prevention and treatment of osteoporosis: a structured review of the literature;Fleurence;Pharmacoeconomics,2007

4. Treatment of established osteoporosis: a systematic review and cost-utility analysis;Kanis;Health Technol Assess,2002

5. Establishing and evaluating FRAX(®) probability thresholds in Taiwan;Chan;J Formos Med Assoc,2017

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Asia-Pacific consensus on long-term and sequential therapy for osteoporosis;Osteoporosis and Sarcopenia;2024-03

2. Validation of self-reported medical condition in the Taiwan Biobank;Journal of Epidemiology;2024

3. Current status, achievements and challenges of osteoporosis care in Taiwan;Journal of the Formosan Medical Association;2023